These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 15627291)

  • 1. Chronic cyclosporine nephrotoxicity: new insights and preventive strategies.
    Li C; Lim SW; Sun BK; Yang CW
    Yonsei Med J; 2004 Dec; 45(6):1004-16. PubMed ID: 15627291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Established and newly proposed mechanisms of chronic cyclosporine nephropathy.
    Yoon HE; Yang CW
    Korean J Intern Med; 2009 Jun; 24(2):81-92. PubMed ID: 19543484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New insights into the pathophysiology of cyclosporine nephrotoxicity: a role of aldosterone.
    Bobadilla NA; Gamba G
    Am J Physiol Renal Physiol; 2007 Jul; 293(1):F2-9. PubMed ID: 17429034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclosporine nephropathy: pathophysiology and clinical impact.
    Shihab FS
    Semin Nephrol; 1996 Nov; 16(6):536-47. PubMed ID: 9125798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Change from cyclosporine to combination therapy of mycophenolic acid with the new sphingosine-1-phosphate receptor agonist, KRP-203, prevents host nephrotoxicity and transplant vasculopathy in rats.
    Fujishiro J; Suzuki C; Kudou S; Yasue T; Hakamata Y; Takahashi M; Murakami T; Hashizume K; Kobayashi E
    J Heart Lung Transplant; 2006 Jul; 25(7):825-33. PubMed ID: 16818126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A role for leukotrienes in cyclosporine nephrotoxicity.
    Butterly DW; Spurney RF; Ruiz P; Griffiths R; Albrightson C; Coffman TM
    Kidney Int; 2000 Jun; 57(6):2586-93. PubMed ID: 10844628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nephrotoxicity of immunosuppressive drugs: new insight and preventive strategies.
    Olyaei AJ; de Mattos AM; Bennett WM
    Curr Opin Crit Care; 2001 Dec; 7(6):384-9. PubMed ID: 11805539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renocortical mRNA expression of vasoactive factors during spironolactone protective effect in chronic cyclosporine nephrotoxicity.
    Pérez-Rojas JM; Derive S; Blanco JA; Cruz C; Martínez de la Maza L; Gamba G; Bobadilla NA
    Am J Physiol Renal Physiol; 2005 Nov; 289(5):F1020-30. PubMed ID: 15998842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic effects of cyclosporine and rapamycin in a chronic nephrotoxicity model.
    Andoh TF; Lindsley J; Franceschini N; Bennett WM
    Transplantation; 1996 Aug; 62(3):311-6. PubMed ID: 8779675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mineralocorticoid receptor blockade confers renoprotection in preexisting chronic cyclosporine nephrotoxicity.
    Pérez-Rojas J; Blanco JA; Cruz C; Trujillo J; Vaidya VS; Uribe N; Bonventre JV; Gamba G; Bobadilla NA
    Am J Physiol Renal Physiol; 2007 Jan; 292(1):F131-9. PubMed ID: 16835406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of transcription factors AP-1 and NF-kappaB in chronic cyclosporine A nephrotoxicity: role in beneficial effects of magnesium supplementation.
    Asai T; Nakatani T; Tamada S; Kuwabara N; Yamanaka S; Tashiro K; Nakao T; Komiya T; Okamura M; Kim S; Iwao H; Miura K
    Transplantation; 2003 Apr; 75(7):1040-4. PubMed ID: 12698095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium antagonists and renal protection from cyclosporine nephrotoxicity: long-term trial in renal transplantation patients.
    Rodicio JL
    J Cardiovasc Pharmacol; 2000; 35(3 Suppl 1):S7-11. PubMed ID: 11347860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclosporine nephrotoxicity: associated allograft dysfunction at low trough concentration.
    Jankauskiene A; Druskis V; Laurinavicius A
    Clin Nephrol; 2001 Dec; 56(6):S27-9. PubMed ID: 11770808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclosporine nephrotoxicity.
    Busauschina A; Schnuelle P; van der Woude FJ
    Transplant Proc; 2004 Mar; 36(2 Suppl):229S-233S. PubMed ID: 15041343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insights into chronic cyclosporine nephrotoxicity.
    Bennett WM
    Int J Clin Pharmacol Ther; 1996 Nov; 34(11):515-9. PubMed ID: 8937936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lazaroids prevent acute cyclosporine-induced renal vasoconstriction.
    Krysztopik RJ; Bentley FR; Spain DA; Wilson MA; Garrison RN
    Transplantation; 1997 May; 63(9):1215-20. PubMed ID: 9158012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrarenal activation of renin angiotensin system in the development of cyclosporine A induced chronic nephrotoxicity.
    Shang MH; Yuan WJ; Zhang SJ; Fan Y; Zhang Z
    Chin Med J (Engl); 2008 Jun; 121(11):983-8. PubMed ID: 18706245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pravastatin treatment attenuates interstitial inflammation and fibrosis in a rat model of chronic cyclosporine-induced nephropathy.
    Li C; Yang CW; Park JH; Lim SW; Sun BK; Jung JY; Kim SB; Kim YS; Kim J; Bang BK
    Am J Physiol Renal Physiol; 2004 Jan; 286(1):F46-57. PubMed ID: 14519596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Novel action of aldosterone in CsA nephrotoxicity].
    Pérez-Rojas JM; Bobadilla NA
    Rev Invest Clin; 2005; 57(2):147-55. PubMed ID: 16524053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ABCB1 genotype of the donor but not of the recipient is a major risk factor for cyclosporine-related nephrotoxicity after renal transplantation.
    Hauser IA; Schaeffeler E; Gauer S; Scheuermann EH; Wegner B; Gossmann J; Ackermann H; Seidl C; Hocher B; Zanger UM; Geiger H; Eichelbaum M; Schwab M
    J Am Soc Nephrol; 2005 May; 16(5):1501-11. PubMed ID: 15772250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.